Björn Cochlovius Email and Phone Number
hello@elevabiologics.comSee: https://lnkd.in/e3uDUYDCBoard experience (including chairman), founder experience, CEO experience.Passionate healthcare professional combining strategic vision and business acumen with strong scientific and product development background. Experience with and understanding of the pharma and biotech scientific and Business Environment. Track record in building new entities (teams, departments, start-ups). Multilingual, accustomed to work in different cultural settings and across cultural borders. International mindset and global positions. Strong international Network, including Asia. Personal and professional Integrity. Ability to make Independent, analytical inquiries and desicions. Expertise in governance, strategy, Finance and funding, corporate and product development.
-
Chief Executive OfficerEleva Jan 2023 - PresentFreiburg, Deutschland (Deu), De
-
Founder And OwnerBc Biomed Consulting Gmbh Jan 2018 - PresentSupport of biotech companies regarding strategy, partnering, M&A, fundraising.Business Development for Atriva Therapeutics.
-
Co-FounderMedraxa Therapeutics Gmbh Oct 2020 - Present
-
Associate Professor (Immunology)Ruprecht-Karls Universitat Heidelberg Medical Faculty May 2003 - PresentTeaching immunology to medical students.
-
Chairman Of The BoardKarolinska Development Jun 2020 - May 2024Solna, Stockholm County, Se -
Chairman Of The BoardSapreme Technologies Bv Nov 2020 - Feb 2024Utrecht, Nl -
Chairman Of The BoardIsogenica Limited Jan 2020 - Jun 2021Little Chesterford, Gb -
Non-Executive Board DirectorIsogenica Limited Oct 2019 - Jun 2021Little Chesterford, Gb
-
Corporate Development Consultant (Part Time)Wuxi Biologics Jun 2019 - Dec 2019Wuxi, Jiangsu, CnCorporate Development Team covering in/out-licensing, strategic partnerships, M&A.Major achievement: negotiated and closed a triple-digit mEUR contract, see below. -
Senior Director Development Japan-Asia-PacificAbbvie Jan 2015 - Jul 2017North Chicago, Illinois, UsResponsibility for Development Strategy and its coordination on global and regional scale for all assets, all countries of Asia-Pacific. Large team (ca 125) in Tokyo. -
Head Strategic Area OncologyOtsuka Feb 2012 - Dec 2014Princeton, Nj, UsBuilding up from scratch a novel Oncology Department in Europe with global reach and own pipeline. -
Co-FounderCiliatech Therapeutics Inc Aug 2011 - May 2013Founder-CEO Aug 2011-Jan 2012; Chairman of the Board Jan 2012-May 2013Virtual biotech company focused on new therapies for Ciliopathies.
-
Director Business DevelopmentRoche Pharmaceuticals Nov 2008 - Jul 2011Switzerland 🇨🇭 , Ch- In-licensing of oncology-assets (preclinical up to clinical phase III): responsibility/project leadership from contact establishment to deal-signature: heading scientific/clinical review, due diligence and negotiation processes).- Support of/involvement in M&A and Roche Venture Fund activities. -
CeoOntarget Neurology Jan 2008 - Oct 2008Virtual start-up company. Projects in Alzheimer's Disease, small molecule drugs. Reporting to Board of Directors.
-
Head R&DAffitech Apr 2004 - Dec 2007Discovery and development of recombinant fully human antibodies for the therapy of cancer and viral infections. Reporting to CEO.
-
Director Preclinical DevelopmentAffitech Sep 2002 - Apr 2004Restructuring of the company's previous focus (diagnostics, infectious diseases) to therapy and oncology. Building-up of a new R&D team. Reporting to CEO.
-
Department Head Recombinant Antibodies(((German Cancer Research Center)))) Jun 2000 - Aug 2002Heidelberg, DeIn vitro and in vivo development of fully human recombinant bispecific antibodies (diabodies, tandem diabodies) for the therapy of rheumatoid arthritis and cancer.Reporting to Institute's Director (NOBEL LAUREATE Prof. Harald zur Hausen). -
Guest Scientist (Embo Scholarship)Weizmann Institute Of Science Apr 2000 - May 2000Rehovot, Hamerkaz, IlDevelopment of recombinant cell-membrane anchored T-cell activating receptors. -
Postdocoral Fellow / Senior ScientistDkfz - German Cancer Research Center Dec 1998 - Mar 2000Heidelberg, DeCo-developer of the novel bispecific antibody format "tandem diabodies": performing in vivo proof-of-concept experiments.
Björn Cochlovius Skills
Björn Cochlovius Education Details
-
Universitat Des Saarlandes Medical SchoolOncology / Molecular Biology -
Universität Des SaarlandesOncology / Immunology / Molecular Biology
-
Universität Des SaarlandesBiology / Biochemistry / Genetics
Frequently Asked Questions about Björn Cochlovius
What company does Björn Cochlovius work for?
Björn Cochlovius works for Eleva
What is Björn Cochlovius's role at the current company?
Björn Cochlovius's current role is - CEO at eleva GmbH- Ph.D., Assoc.Prof.- Opinions are my own..
What schools did Björn Cochlovius attend?
Björn Cochlovius attended Universitat Des Saarlandes Medical School, Universität Des Saarlandes, Universität Des Saarlandes.
What are some of Björn Cochlovius's interests?
Björn Cochlovius has interest in Some Spanish, Basic Italian, Norwegian, Languages, Interests, English, Travel To Learn About Foreign Cultures, Scuba Diving, French, Mountain Hiking.
What skills is Björn Cochlovius known for?
Björn Cochlovius has skills like Biotechnology, Clinical Development, Oncology, Pharmaceutical Industry, Clinical Trials, Immunology, Drug Development, Strategy, Lifesciences, Cancer, Drug Discovery, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial